chr17-42680177-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_016602.3(CCR10):āc.465C>Gā(p.Pro155=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00215 in 1,610,730 control chromosomes in the GnomAD database, including 58 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.011 ( 27 hom., cov: 33)
Exomes š: 0.0012 ( 31 hom. )
Consequence
CCR10
NM_016602.3 synonymous
NM_016602.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.97
Genes affected
CCR10 (HGNC:4474): (C-C motif chemokine receptor 10) Chemokines are a group of small (approximately 8 to 14 kD), mostly basic, structurally related molecules that regulate cell trafficking of various types of leukocytes through interactions with a subset of 7-transmembrane, G protein-coupled receptors. Chemokines also play fundamental roles in the development, homeostasis, and function of the immune system, and they have effects on cells of the central nervous system as well as on endothelial cells involved in angiogenesis or angiostasis. Chemokines are divided into 2 major subfamilies, CXC and CC, based on the arrangement of the first 2 of the 4 conserved cysteine residues; the 2 cysteines are separated by a single amino acid in CXC chemokines and are adjacent in CC chemokines. CCR10 is the receptor for CCL27 (SCYA27; MIM 604833); CCR10-CCL27 interactions are involved in T cell-mediated skin inflammation (Homey et al., 2002 [PubMed 11821900]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 17-42680177-G-C is Benign according to our data. Variant chr17-42680177-G-C is described in ClinVar as [Benign]. Clinvar id is 785571.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.97 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0109 (1661/152162) while in subpopulation AFR AF= 0.0376 (1562/41518). AF 95% confidence interval is 0.0361. There are 27 homozygotes in gnomad4. There are 762 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 27 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCR10 | NM_016602.3 | c.465C>G | p.Pro155= | synonymous_variant | 2/2 | ENST00000332438.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCR10 | ENST00000332438.4 | c.465C>G | p.Pro155= | synonymous_variant | 2/2 | 1 | NM_016602.3 | P1 | |
ENST00000593139.1 | n.215G>C | non_coding_transcript_exon_variant | 1/3 | 5 | |||||
CCR10 | ENST00000591568.1 | c.-202C>G | 5_prime_UTR_variant | 2/2 | 3 | ||||
CCR10 | ENST00000591765.1 | c.-202C>G | 5_prime_UTR_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0109 AC: 1657AN: 152044Hom.: 27 Cov.: 33
GnomAD3 genomes
AF:
AC:
1657
AN:
152044
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00267 AC: 635AN: 238024Hom.: 4 AF XY: 0.00201 AC XY: 262AN XY: 130556
GnomAD3 exomes
AF:
AC:
635
AN:
238024
Hom.:
AF XY:
AC XY:
262
AN XY:
130556
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00124 AC: 1807AN: 1458568Hom.: 31 Cov.: 31 AF XY: 0.00105 AC XY: 762AN XY: 725472
GnomAD4 exome
AF:
AC:
1807
AN:
1458568
Hom.:
Cov.:
31
AF XY:
AC XY:
762
AN XY:
725472
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0109 AC: 1661AN: 152162Hom.: 27 Cov.: 33 AF XY: 0.0102 AC XY: 762AN XY: 74402
GnomAD4 genome
AF:
AC:
1661
AN:
152162
Hom.:
Cov.:
33
AF XY:
AC XY:
762
AN XY:
74402
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at